Castle Biosciences Inc (CSTL)
20.46
+0.95
(+4.87%)
USD |
NASDAQ |
Apr 26, 15:16
Castle Biosciences Gross Profit Margin (Quarterly): 81.21% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 81.21% |
September 30, 2023 | 81.59% |
June 30, 2023 | 77.94% |
March 31, 2023 | 75.78% |
December 31, 2022 | 75.17% |
September 30, 2022 | 76.06% |
June 30, 2022 | 77.94% |
March 31, 2022 | 77.86% |
December 31, 2021 | 81.64% |
September 30, 2021 | 80.83% |
June 30, 2021 | 83.76% |
March 31, 2021 | 86.73% |
Date | Value |
---|---|
December 31, 2020 | 84.55% |
September 30, 2020 | 83.74% |
June 30, 2020 | 83.12% |
March 31, 2020 | 86.27% |
December 31, 2019 | 88.60% |
September 30, 2019 | 88.44% |
June 30, 2019 | 81.44% |
March 31, 2019 | 81.67% |
December 31, 2018 | 88.05% |
September 30, 2018 | 63.61% |
June 30, 2018 | 66.66% |
March 31, 2018 | 65.75% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
75.17%
Minimum
Dec 2022
88.60%
Maximum
Dec 2019
81.72%
Average
81.59%
Median
Sep 2023
Gross Profit Margin (Quarterly) Benchmarks
Exact Sciences Corp | 73.44% |
Illumina Inc | 60.07% |
Mettler-Toledo International Inc | 59.00% |
Waters Corp | 61.15% |
Natera Inc | 51.38% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -14.81% |
Return on Assets | -13.13% |
Return on Invested Capital | -14.81% |
Profit Margin (Quarterly) | -3.90% |
Operating Margin (Quarterly) | -8.56% |
Return on Net Operating Assets | -30.08% |